| Similar Articles |
|---|
 |
The Motley Fool
November 13, 2006
Jack Uldrich |
Arrowhead: A Long-Term RNAi Play? Its majority stake in Calando Pharmaceuticals could pay dividends. Investors would be wise to continue to watch this company and wait until clinical trials have advanced to a more mature stage before considering an investment.   |
Fast Company
September 2006
Michael Fitzgerald |
Nano Is Nice Bruce Stewart plans to make money with a daring approach to funding technology: He's trying to corner key nanotechnology research, then develop it commercially. His company, Arrowhead Research Corp., has assembled more than 160 key patents in nanotech. |
The Motley Fool
April 28, 2005
Carl Wherrett |
Nano Moves to the Mainstream Some nanotech investments aim to bridge the commercial gap. Are they worth a look? Arrowhead Research... Competitive Technologies... Advance Nanotech... |
The Motley Fool
August 9, 2006
Jack Uldrich |
A Tiny Nanotech IP Play Harris & Harris owns an equity stake in valuable nanotech intellectual property. Investors, take note. |
The Motley Fool
February 9, 2006
Jason Mac Gurn |
RNA: Rule Breaker Nucleic Acid Investors, new RNA-based technologies may be the next revolution in biopharmaceuticals. ISIS Pharmaceuticals... Sirna Therapeutics... Alnylam Pharmaceuticals... |
The Motley Fool
November 21, 2006
Jack Uldrich |
A Good ETF: PowerShares Lux Nanotech This nanotech fund has many strengths, but also a few weaknesses. |
The Motley Fool
January 6, 2006
Jack Uldrich |
2005 Gave Nanotech Investors Plenty to Chew On For investors who have been holding off investing in nanotechnology because they thought there was more "sizzle" than "steak," here are some developments that offer plenty to chew on. |
The Motley Fool
September 22, 2005
Jack Uldrich |
TINY Magnifies Its Hunt The nanotech venture capital firm announces its participation in two big nano private financings. Investors, take note. |
The Motley Fool
December 5, 2006
Jack Uldrich |
A TINY Dose of Patience A lack of nanotech IPOs could hinder short-term returns for Harris & Harris. For all of nanotech's promise, investing in it remains a risky game. |
The Motley Fool
August 15, 2006
Ralph Casale |
Sirna Battles Genes Gone Bad Pharmaceutical start-up Sirna Therapeutics tests drugs to silence rogue genes. Investors, while drugs based on RNA interference may have the potential to become the next big thing in biotechnology, they're still a long, long way from becoming FDA-approved, marketable entities. |
The Motley Fool
January 9, 2006
Jack Uldrich |
More Big 2005 Nanotech News A recap roundup of big news in tiny tech continues: When Fortune 500 companies weren't partnering with or acquiring promising nanotechnology startups, many of them were investing heavily in their own nanotechnology-related research and development. Investors, take note. |
The Motley Fool
November 6, 2006
Jack Uldrich |
TINY Investment Inches Closer to Payoff Carbon nanotubes move into semiconductor production fabs. Until more details are forthcoming, investors are cautioned against getting too excited. |
The Motley Fool
November 13, 2006
Jack Uldrich |
Prepare Your Retirement for a Big Bang Investors should plan on living longer than expected. |
The Motley Fool
October 28, 2005
Jack Uldrich |
A New Nanotech Fund The PowerShares fund tries to make it easier to invest in nanotech. But the choice of companies could have been better. |
The Motley Fool
July 10, 2007
Jack Uldrich |
Welcome to My Tiny World Investors, in this interview, venture capitalist Charles Harris shows he knows his way around the high-risk, high-reward world of nanotechnology. |
The Motley Fool
May 16, 2005
Carl Wherrett |
The Next Tech Revolution At the smallest scale known to man lies the future of civilization. But what of investors? Should our portfolios take notice of this emerging, but as yet commercially unproven, technology? |
The Motley Fool
December 7, 2004
Wherrett & Yelovich |
Lemons Ripen Faster Than Plums A venture capitalist in the nano sector is finding some nice pickings. However, valuing Harris is not an easy task, as the metrics of sales and profits are not relevant to a publicly traded VC company. |
The Motley Fool
August 19, 2005
Jack Uldrich |
GE: Bringing "Small" Things to Life GE, the world's largest and most diversified company, has targeted nanotechnology as one of the keys to its future success. The patient, long-term investor could be well-rewarded. |
The Motley Fool
July 20, 2007
Jack Uldrich |
A TINY Opportunity in Nanosys' News High-capacity flash-memory technology could be a boon to venture capital firm Harris & Harris. |
The Motley Fool
August 23, 2005
Jack Uldrich |
Invest With the CIA Venture capital firm Harris & Harris has stakes in nanotechnology, one tool the government is using to protect us. Is it time to invest? |
The Motley Fool
August 8, 2006
Jack Uldrich |
Beware the Nano Lawyers Growing confusion over nanotechnology-related patents could snare investors. Investors need to consider the strength of a company's intellectual property (IP) portfolio. |
BusinessWeek
February 7, 2005
Gene G. Marcial |
Why Arrowhead May Outshoot The Nanotechs The 27-stock nanotech index has been flat since its Apr. 1 launch. One stellar performer, however, Arrowhead Research, could be the "wild card" among the nanotechs because of its close ties with Caltech. |
The Motley Fool
October 27, 2006
Jack Uldrich |
Nanotech and the War on Cancer New imaging advances in nanotechnology will help speed cancers' end. What does it mean for investors? |
The Motley Fool
May 26, 2006
Jack Uldrich |
Harris & Harris Seeks Some Sun and Surf If you're looking for a little sun (in the form of solar power) and fun (in the form of quantum computing), you might want to consider an investment in Harris & Harris. |
The Motley Fool
August 4, 2005
Jack Uldrich |
3M: Great at the Little Things The maker of Scotch Tape, Post-It Notes, and Thinsulate is also a nanotech powerhouse well-positioned to employ the emerging science of the small across its entire line of diversified products. Investors, take note. |
Entrepreneur
May 2008
Andrea Cooper |
Small Wonders In the world of nanotechnology, good things come in really small packages. |
The Motley Fool
October 26, 2007
Jack Uldrich |
DuPont Shuns Heavy Metal The chemical company teams up with nanotech firms to develop high-performance plastics. Investors, take note. |
The Motley Fool
March 16, 2004
Wherrett & Yelovich |
Nano Goes to Wall Street Are you ready for the first nanotechnology mutual fund? |
IndustryWeek
January 1, 2008
Jill Jusko |
Growth Spurt for Nano: By the Numbers More than $50 billion in nano-enabled products sold worldwide last year. |
IndustryWeek
June 22, 2011 |
Regulators Will Control Nanotechnology Future Nanotechnology promises great advances for a host of industries, but concerns about health and safety threaten commercialization efforts. |
Bio-IT World
March 8, 2005
Salvatore Salamone |
Nano Poised for Liftoff First 'nano' technologies yield fruit in the biomedical lab and clinic with the promise of more to come. |
The Motley Fool
May 12, 2005
Carl Wherrett |
TINY's Tiny Decrease Smart investors should be looking at Harris & Harris' drop in net asset value due to a depreciation in the value of the 1.1 million shares still held by the VC company NeuroMetrix as an opportunity. |
The Motley Fool
December 21, 2005
Carl Wherrett |
FUD Fight Over Nanotech Responsible research should quell fear, uncertainty, and doubt (FUD) over nanotechnology. And that includes investing fears. |
CIO
January 1, 2003
Julie Hanson |
The Next Little Thing Perhaps the Next Big Thing on the horizon, nanotechnology is the science of manipulating materials on an atomic or molecular scale. |
Military & Aerospace Electronics
September 2004
John McHale |
Nanotechnology: The Revolution Has Begun Nanotechnology, heavily researched and funded across the globe, promises to revolutionize many applications in space flight and communications. The advanced miniaturization concepts will proliferate across many industries in addition to defense and aerospace. |
IndustryWeek
August 1, 2005
John Teresko |
Two Steps Forward, One Back? Leaders such as Motorola and IBM have embraced nanomaterials, but by spending less on R&D, the U.S. manufacturing sector could be stumbling in the race for more innovative products. |
IndustryWeek
April 1, 2003
John Teresko |
The Next Material World Get ready to research, reengineer, reinvent and innovate new products and processes. The National Science Foundation has predicted a $1 trillion market by 2015 for nano products. |
Chemistry World
October 6, 2010
Hayley Birch |
US roadmap for nano development Nanotechnology is one of the largest and most competitive research fields globally, with the market for nanotechnology-based products exceeding $250 billion. |
Reason
December 2003
Ronald Bailey |
The Smaller the Better The limitless promise of nanotechnology -- and the growing peril of a moratorium. |
Food Processing
September 2009
Ronald Wernette |
Nanotechnology Coming to Your Store The current number of food products using nanotechnology is relatively small. Nevertheless, hundreds of research projects are under way and tens of millions of dollars are being spent in a global race to apply nanotechnologies in food production, processing and packaging. |
The Motley Fool
May 26, 2006
Jack Uldrich |
Big Business Gets Small Few, if any, companies are safe from the relentless forces of technological change. What, then, is a long-term investor to do? Three big players look to nanotech as key to their continued performance. |
Popular Mechanics
October 2006
Glenn Harlan Reynolds |
Nanotechnology: Good Things in Small Packages Critics exaggerate the dangers. Boosters flog the benefits. Let's give nanotechnology a chance to develop before we start taking sides. |
The Motley Fool
October 26, 2005
Tim Beyers |
Top Floor: Space NASA opens space elevator competition to private companies. But you needn't wait for investing opportunities. Carbon nanotubes are expected to play a major role here, and that's good news for small pure-play nano firms, such as Harris & Harris and Arrowhead Research. |
